These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28915691)

  • 1. Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort).
    Zhang JW; Huang L; Xu AM
    Oncotarget; 2017 Aug; 8(34):57516-57527. PubMed ID: 28915691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
    Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P; Ma G; Liu Y; Ke B; Liu HM; Liang H; Zhang RP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):54-62. PubMed ID: 38262901
    [No Abstract]   [Full Text] [Related]  

  • 4. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
    Zhang L; Su Y; Chen Z; Wei Z; Han W; Xu A
    Medicine (Baltimore); 2017 Jul; 96(30):e7647. PubMed ID: 28746229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis.
    Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB
    Front Oncol; 2020; 10():178. PubMed ID: 32154173
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-to-lymphocyte ratio is correlated with a delay in feeding resumption following a transhiatal esophagectomy with cervical anastomosis.
    El Asmar A; Ghabi E; Saber T; Abou-Malhab C; Akl B; El Rassi Z
    World J Surg Oncol; 2020 Oct; 18(1):267. PubMed ID: 33054830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort.
    Huang L; Wei ZJ; Li TJ; Jiang YM; Xu AM
    Oncotarget; 2017 Sep; 8(40):68165-68179. PubMed ID: 28978106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
    Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM
    Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort.
    Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY
    Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
    Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
    J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
    Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
    Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M; Yamashita H; Watanabe T; Seto Y
    World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer.
    Zheng L; Xiong A; Wang S; Xu J; Shen Y; Zhong R; Lu J; Chu T; Zhang W; Li Y; Zheng X; Han B; Zhong H; Nie W; Zhang X
    Front Immunol; 2023; 14():1094378. PubMed ID: 36776882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
    Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
    J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer.
    Chen H; Wu X; Wen Z; Zhu Y; Liao L; Yang J
    Arch Esp Urol; 2022 Jun; 75(5):467-471. PubMed ID: 35983820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma.
    Romano L; Giuliani A; Tomarelli C; Nervini A; Lazzarin G; Pessia B; Vicentini V; Carlei F; Schietroma M
    Med Princ Pract; 2022; 31(6):586-594. PubMed ID: 36323225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
    Huang L; Fang J; Wu J; Zhou X; Wei H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer.
    Song H; Jeong MJ; Cha J; Lee JS; Yoo JG; Song MJ; Kim JH; Lee SJ; Lee HN; Yoon JH; Park DC; Kim SI
    Int J Med Sci; 2021; 18(16):3712-3717. PubMed ID: 34790044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.